Background-We recently developed a 4F child catheter that can be inserted into 6F or larger conventional guiding catheters.
S ince the completion of the first human percutaneous coronary balloon angioplasty in 1977 by Gruentzig, 1 angioplasty equipment has continued to become increasingly miniaturized. [2] [3] [4] [5] [6] In fact, although 9F to 10F guiding catheters were used in the early years of percutaneous coronary intervention (PCI), 6F guiding catheters have now become established as the standard for most PCI cases.
Clinical Perspective on p 161
When treating complex coronary lesions, however, the backup support of a 6F guiding catheter is often insufficient. To overcome this disadvantage, several strategies have been proposed, which include active/passive guiding-catheter support, wire support, anchor balloon technique, the Tornus device (Asahi Intecc, Nagoya, Japan), and the Proxis catheter (St Jude Medical, St Paul, MN). 7 We previously proposed a technique named as the mother-child 5-in-6 technique. 8 The 5F child guiding catheter (ST01, Terumo, Tokyo, Japan) comes with a long catheter length of 120 cm. Introduction of a 5F child guiding catheter within the coronary artery through 6F mother-guiding catheter generates strong backup support. However, in-depth insertion of a 5F child catheter into the coronary artery is often difficult and compromises the coronary flow, especially in case of diffusely diseased vessels and those with excessive tortuosity.
We have recently developed a 4F coronary accessor (Kiwami, Terumo) designed to access the coronary artery and to deliver coronary stents. 2 Because the inner diameter of this catheter is 1.27 mm (0.050 inch), it can accommodate most currently available coronary stents. In addition, because of its small outer diameter of 1.43 mm (0.056 inch), it can also be used as a child catheter for conventional 6F or larger guiding catheters ( Table 1 and Figure 1 ).
In the present study, we assessed the potential of the mother-child technique of 4-in-6 using an in vitro coronary tree model. In addition, the clinical outcome of the 4F mother-child technique was retrospectively evaluated. To the best of our knowledge, this is the first report demonstrating the potential of this novel technique in treating complex coronary lesions.
Methods
The 4F and 5F Child Guiding Catheters Details of the 5F child guiding catheter have previously been described elsewhere. 8 Briefly, the length of a 5F child catheter is 120 cm, that is, 20 cm longer than that of a conventional guiding catheter (100 cm). The inner diameter of the mother catheter must be Ͼ1.80 mm (0.071 inch) to accommodate the 5F child catheter because the outer diameter of the 5F catheter is 1.73 mm (0.068 inch) ( Table 1 ). Among currently available 6F guiding catheters, Launcher (Medtronic, Minneapolis, MN), Taiga (Medtronic), Heartrail (Terumo), and Radiguide (Terumo) meet this requirement.
The 4F straight child catheter is currently available from 2 different manufacturers, Terumo and Asahi Intecc (Nagoya, Japan). These 2 child catheters are similar in their specifications: length, 120 cm and inner diameter, 1.27 mm (0.05 inch), and they are associated with flexibility and trackability that are optimized for deep insertion into the coronary artery. The only difference in these 2 catheters is that the outer diameter of the one manufactured by Terumo is slightly smaller than that by Asahi Intecc: 1.43 mm (0.056 inch) and 1.50 mm (0.059 inch), respectively. This difference in outer diameter mandates that the one from Asahi cannot be used in combination with a 5F mother guiding catheter.
In Vitro Experiments
The potential of the mother-child technique of 4-in-6 was investigated using a modified model of coronary tree described previously 8, 9 (Figure 2A and Figure 3A and 3B). The arterial tree was constructed of silicon tubes filled with water at 37°C. The inner diameters of the tube representing the vessels were 35 mm for the aorta and 4 mm at the coronary ostium, with gradual tapering down to 2 mm at the distal coronary artery. The arterial tree was three-dimensional, and had 4 curves simulating tortuous coronary arteries.
For the measurement of the backup force of a guiding catheter, 6F, 7F, and 8F Judkins left 4.0 guiding catheters (Terumo) were cannulated into the ostium of the coronary tree. A 3.5ϫ10-mm Tsunami stent (Terumo) was then automatically pushed into the coronary tree model along a 0.014-inch Runthrough NS floppy guide wire (Terumo) at a constant speed of 5 mm/s using a pushable gauge machine. The pushing force of the gauge machine represented the resistance of a stent delivery system during the advancement of stents. The maximal backup support of the guiding catheter was thus defined as the pushing force of the gauge machine when the guiding catheter disengaged from the coronary ostium.
The backup support was also measured for the 4-in-6 or the 5-in-6 systems using the same coronary tree model. After inserting the child catheter (4F or 5F ST01) into the coronary tree model out of the 6F mother guiding catheter (Judkins left 4.0) by 0, 1, 3, 5, and 9 cm (Figure 2A ), the stent delivery system was advanced into the coronary tree model at a constant speed of 5 mm/s using the gauge machine. The maximal backup support of the mother-child guiding system was defined as the pushing force of the gauge machine when the mother guiding catheter disengaged from the coronary ostium.
For the assessment of the trackability of the 4F and 5F child catheters, a 3.5ϫ15-mm Ryujin Plus balloon (Terumo) was inflated in the distal coronary tree at the rated burst pressure of 12 atm to maximize the anchoring support of the mother-child system. The child catheter was then advanced into the coronary tree as distally as possible by using a balloon-anchoring technique. The trackability of the child catheter was assessed by measuring the length (cm) between the tips of the 4F child catheter and the mother guiding catheter ( Figure 3A and 3B).
Study Patients
Between December 2008 and September 2010, a total of 51 patients were treated by using the 4F mother-child technique. This technique was used, based on the operator's discretion, when a balloon or a stent failed to cross the lesion using conventional PCI techniques.
Mother-Child Technique
The methods for mother-child technique have been described in detail previously. 8 First, when a balloon or a stent failed to cross the target lesion, these devices were removed from the guiding catheter while the PCI guide wire remained in situ. Then, the Y-connector was disconnected from the guiding catheter; instead, a small hemostatic valve was connected. Next, a 4F child catheter was inserted into the mother guiding catheter along the PCI guide wire. During this step, care was taken not to advance the child catheter beyond the distal tip of the mother guiding catheter. It should be mentioned that although the 4F child catheter has an over-the-wire configuration (Figure 1 ), it can be advanced into the mother guiding catheter without use of exchanging-length guide wires. (Note: Removal of the child catheter while the PCI guide wire remained in situ requires exchanging-length guide wires.) Subsequently, the Y-connector was connected to the child catheter, through which the balloon catheter was advanced to the lesion. By using an anchor balloon technique, the child catheter was advanced to the target lesion, that is, the 4F child catheter was advanced out of the mother guiding catheter during the balloon inflation with a slight tension on the shaft of the balloon catheter. This step was important for avoiding possible intimal injury by the tip of the child catheter. Finally, the balloon catheter was removed, while the child guiding catheter was placed near the target lesion; the balloon or the stent which had previously failed to cross the target lesion was advanced through the child catheter and then inflated/deployed.
Lesion success was defined as achievement of a target lesion percent diameter stenosis Ͻ50% by any methods; device success was defined as lesion success achieved by stent deployment; and procedure success was defined as lesion success without in-hospital major adverse cardiac events as a composite of cardiac death, myocardial infarction, and target lesion revascularization. Creatine phosphokinase-MB was routinely measured after PCI, and an increase greater than 3-fold of the upper limit of the normal values was considered to represent myocardial infarction.
Statistical Analysis
Continuous data are expressed as meanϮstandard deviation or median (quartiles 1 to 3) and categorical data, as frequencies and percentages, unless otherwise indicated. When multiple lesions were treated, only the most distally located lesion was used for the 
analysis because the delivery of coronary stent was generally most difficult to the lesion that was located in the distal coronary artery. Statistical comparisons were performed with the Mann-Whitney or the Kruskal-Wallis test followed by the Scheffe procedure using the StatView application (version 5.0 for Windows, SAS Institute Inc, Cary, NC). A 2-tailed probability value of Ͻ0.05 was considered statistically significant.
Results

Backup Support of Conventional Guiding Catheters In Vitro
The backup support of conventional 6F, 7F, and 8F guiding catheters was evaluated in vitro without use of a child catheter ( Figure 2B ). The backup support of the 6F guiding catheter (1.10 N [0.99 to 1.21 N]) was significantly lower than that of the 7F and 8F ones (2.00 N [1.95 to 2.05 N] and 2.69 N [2.65 to 2.75 N], respectively; PϽ0.0001 for both, nϭ5 for each).
The backup support of a 7F guiding was significantly lower than that of the 8F one (PϽ0.005).
Backup Support of Mother-Child Systems In Vitro
The backup support of the mother-child system was also evaluated in vitro (nϭ5 for each). When inserting a 5F child catheter into a 6F mother guiding catheter but not extending beyond the tip of a mother catheter, the backup support of a 5-in-6 system (0 cm: When inserting the 4F child catheter into the 6F mother guiding catheter but not extending beyond the tip of the mother guiding catheter, the backup support of the 4-in-6 system (0 cm: 1.16 N [1.07 to 1.20 N]) was similar to that of a 6F guiding catheter alone. It significantly increased by extending the child catheter Ն5 cm beyond the tip of the mother guiding catheter (5 cm: 1.74 N [1.72 to 1.80 N], Pϭ0.01; and 9 cm: 2.15 N [2.01 to 2.29 N], PϽ0.0001) ( Figure 2D ). However, even with extending the child catheter by 9 cm, the backup support of the 4-in-6 system did not exceed the level of the 7F guiding catheter (2.15 N [2.01 to 2.29 N] versus 2.00 N [1.95 to 2.05 N], PϭNS).
Trackability of a Child Catheter In Vitro
The trackability of the 4F and 5F child catheters was evaluated by measuring the distance between the tips of the mother and the child guiding catheters. The trackability of the 4F child catheter was significantly superior to that of the 5F child catheter (15.0 cm [15.0 to 15.0 cm] versus 13.0 cm [12.8 to 13.0 cm], PϽ0.005; nϭ5 for each) (Figure 3 ). It should be mentioned that the 5F child catheter could be advanced Ϸ13.0 cm distal to the ostium of the coronary tree. The inner diameter of the coronary tree around this part was greater than the outer diameter of the 5F child catheter. Thus, the tapering of the coronary tree did not limit the trackability of the 5F catheter. It should also be pointed out that although the difference in the length of the child and the mother catheters was 20 cm, the presence of the hemostatic valve and The maximal backup support of the guiding catheter was defined as the pushing force of the gauge machine when the mother guiding catheter disengaged from the coronary ostium (large arrow). B, Backup support of a conventional guiding system. The backup support of conventional 6F, 7F, and 8F guiding catheters was evaluated without use of a child catheter (*PϽ0.0001 versus 6F; †PϽ0.005 versus 7F). C, Backup support of the 5-in-6 system. By extending a 5F child catheter Ն3 cm, the backup support of the 5-in-6 system significantly increased (*PϽ0.0001 versus 0 cm; †PϽ0.05 versus 1 cm; ‡PϽ0.0001 versus 1 cm; §PϽ0.0001 versus 3 cm; and ¶PϽ0.0005 versus 5 cm). D, Backup support of the 4-in-6 system. By extending a 4F child catheter Ն5 cm, the backup support of the 4-in-6 system significantly increased (*Pϭ0.01 versus 0 cm; †PϽ0.0001 versus 0 and 1 cm; ‡PϽ0.0001 versus 3 cm).
the hubs of both the catheters limited the advancement of the 4F child catheter to Ϸ15 cm.
Patient Characteristics
The clinical study included 51 consecutive patients who underwent PCI using the 4F mother-child technique. The demographic data of the patients are provided in Table 2 . The mean age was 70.8Ϯ6.9 years (range, 59 to 85 years), and 38 (75%) were men. All patients had multivessel disease, and 34 (67%) had 3-vessel or left main trunk disease. Vessels treated were 17 (33%) left anterior descending arteries, 11 (22%) circumflex, 21 (41%) right coronary, and 2 (4%) bypass grafts. The morphologies of the lesions consisted of 9 (18%) type B2 and 42 (82%) type C. No type A/B1 lesions were observed.
Procedural Characteristics
Procedural characteristics of the 4F mother-child technique are provided in Table 3 . PCI was carried out via the radial route in 36 of 51 (71%) patients, brachial in 1 (2%), and femoral in 14 (27%). The size of the mother guiding catheters was 6F in 40 (78%) patients, 7F in 9 (18%), and 8F in 2 (4%). The shapes of the mother guiding catheters were extra backup left in 27 (53%) patients, Amplatz left in 20 (39%), Ikari left in 1 (2%), Ikari right in 2 (4%), and internal mammary artery in 1 (2%). No Judkins-type catheters were used. Thirty-seven of 51 (73%) treated lesions were associated with moderate to severe calcification ( Figure 4 ). Nineteen (37%) had excessive proximal tortuosity ( Figure 5 ), and 4 (8%) were extremely bent at the site of stenosis. Four (8%) lesions were after the failed mother-child technique of 5-in-6.
Lesion success was achieved in 48 of 51 (94%) lesions. Stent deployment was attempted in 44 lesions and was successful in 40 (91%) lesions in which a total of 40 stents were implanted. Implanted stents were 18 (45%) Taxus (Boston Scientific, Maple Grove, MN), 9 (23%) Cypher (Cordis Europe, Roden, The Netherlands), 8 (20%) Endeavor (Medtronic), 2 (5%) Tsunami, 2 (5%) Liberte (Boston Scientific), and 1 (2%) Xience V (Abott Vascular, Santa Clara, CA) stents. The median stent diameter was 2.8 mm (2.5 to 3.0 mm), and the median stent length was 23.0 mm (20.0 to 30.0 mm).
Overall, procedural success was achieved in 48 of 51 (94%) patients. The main reasons for procedural failure were severe calcification and tortuosity of the proximal segment or of the target lesion itself. There were 2 instances of stent dislodgment during withdrawal of the stent delivery system back into the child catheter. These stents could not be retrieved and were thus deployed or crushed at the nontarget coronary segments. 
Procedural Complications
The use of 4F child catheter was not associated with proximal vessel dissection, wire perforation, or distal embolization. Two of 51 (4%) patients had non-Q-wave myocardial infarction, both of which were due to acute closure of the target lesion after the balloon predilatation. There were no deaths, Q-wave myocardial infarctions, or in-hospital target vessel surgical or percutaneous revascularizations.
Discussion
The application of a catheter-based approach for the treatment of coronary artery disease was first introduced by Gruentzig 1 more than 3 decades ago. Subsequently, during the past 2 decades, a variety of new devices have been developed as a means of potentially reducing restenosis; these include directional coronary atherectomy, laser angioplasty, rotational atherectomy, cutting balloon, bare-metal stents, and drug-eluting stents. Among these, the drug-eluting stent is certainly the most powerful tool, which has successfully reduced the need for revascularization of the target lesion to Ͻ5%. 10, 11 Introduction of the drug-eluting stent has not only reduced restenosis but also dramatically changed the strategies of PCI. In fact, a significant proportion of patients are now being treated by simple stent implantation with or without a combination of balloon dilatation. In this regard, the advent of the 4F child catheter for delivering stents in complex coronary lesions represents an important advancement in the PCI technique.
Mechanisms for Successful Mother-Child Technique
The lesions treated in this study included only type B2/C lesions, with Ͼ80% of type C lesions. In addition, 8% of patients were those in whom the 5F mother-child technique had failed. Despite such complexity of the target lesions, the use of the 4F mother-child technique resulted in favorable clinical outcomes. The results of the in vitro experiments suggests that the success of the 4F mother-child technique may be achieved by the increased backup support of the mother-child system in combination with the superb trackability of the child catheter in reaching the target lesion. However, the increase in backup support observed with the 4-in-6 system in vitro was not robust. Therefore, success of the 4F mother-child technique may be contributed, in most part, by the trackability of the 4F child catheter. It should also be mentioned that the deep insertion of a 4F child catheter does not usually compromise the coronary flow. This may be due to the small size profile of the 4F child catheter. In addition, balloon predilatation of the coronary lesions, a prerequisite for the 4-in-6 technique, might also contribute to the uncompromised coronary flow.
As mentioned above, one of the drawbacks of the 4F mother-child system is its limited backup support. The in vitro system demonstrated that the 5F mother-child system could generate strong backup support that exceeded an 8F guiding catheter. In contrast, the maximum backup support that can be created by the 4F mother-child system did not exceed a 7F guiding catheter. In particular, deep intubation of the 4F child catheter Ͻ5 cm failed to generate an increase in the backup support. It is thus suggested that when expecting an increase in backup support to deliver stents, 5F rather than 4F is the appropriate choice for a child catheter.
Stent Dislodgment With the 4F Mother-Child System
We had 2 instances of stent dislodgment during withdrawal of the stent delivery system back into the 4F child catheter. Because coronary lesions that may require the use of the 4-in-6 technique are usually associated with excessive tortuosity and calcification, retrieving the stent after failed delivery appears difficult and is associated with high risks of stent dislodgment. This point differs from our previous experiences with 4F PCI in which the 4F catheter was used as a sole guiding catheter. 2, 3 Because 4F PCI is targeted at relatively simple lesions, retrieving the stents after delivery failure is often successful. In fact, a recent study has indicated that more than 50% of lesions treated by 4F PCI belonged to type A/B1, and that no stent dislodgment was observed. 3 Physicians are advised to be cautious in this regard, that is, the lesions treated by 4F PCI and the 4-in-6 system are different in nature; therefore, the risk of stent dislodgment is higher with the 4-in-6 procedure. In addition, retrieving the dislodged stent would also be difficult in patients who require the 4-in-6 procedure for stent delivery. Thus, if stent dislodgment occurs during the 4-in-6 procedure, either deploying or crushing the dislodged stent within the coronary artery is the recommended course of action.
Limitations of the 4F Mother-Child System
Finally, as is the case in 4F PCI, the small diameter of the 4F child catheter limits the use of intravascular ultrasound and some of the coronary stents. 2, 3 It is also important to note that certain techniques, such as kissing balloon inflations 12, 13 and use of a buddy wire, 14 are not allowed with the 4F system.
Study Limitations
In the in vitro study, the backup support of the guiding system was measured when a slight disengagement of the mother catheter was observed. However, the extent to which these backup forces that we measured in vitro correlate with those in the clinical setting remains unknown. There exists certain friction between the 4F child catheter and the 6F mother catheter. This increases when the child catheter passes the curved portion of the mother catheter and decreases when passing the straight portion. The degree of friction also changes, depending on the device being inserted into the 4F child catheter. The current in vitro study did not take into account these varying frictions when measuring the backup force. It should be pointed out, however, that such frictions are usually small, and unlikely to be a clinical problem.
Conclusions
With the superior trackability of the 4F child catheter in combination with the increased backup support of the mother-child system, the 4F mother-child technique provided Ͼ90% success rate for lesions in which conventional techniques had been unsuccessful. This new technique may become a viable alternative to conventional PCI techniques for the treatment of complex coronary lesions.
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